Comparison of Everolimus- and Biolimus-Eluting Stents With Everolimus-Eluting Bioresorbable Vascular Scaffold Stents II | Clinical Trial - EVERBIO II


The goal of the trial was to compare angiographic outcomes between bioresorbable vascular scaffold stents (BVS), biolimus-eluting stents (BES), and everolimus-eluting stents (EES).

Contribution to the Literature: This study suggests similar angiographic outcomes at 9 months between BVS, BES, and EES.